Movement Disorders: Less of a Black Box

Shake the family tree of a patient with a movement disorder, and more and more genes are apt to tumble out. Parkinson's disease and many less well-known movement disorders are now considered to be more familial than scientists had previously thought. "When it comes to Parkinson's disease, the important role of genetics as a decisive factor in the appearance and evolution of the disease is gaining more and more ground," says Eduard Tolosa, chairman of the department of neurology at the University

Written byJean Mccann
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Shake the family tree of a patient with a movement disorder, and more and more genes are apt to tumble out. Parkinson's disease and many less well-known movement disorders are now considered to be more familial than scientists had previously thought. "When it comes to Parkinson's disease, the important role of genetics as a decisive factor in the appearance and evolution of the disease is gaining more and more ground," says Eduard Tolosa, chairman of the department of neurology at the University of Barcelona and chairman of the recent Sixth International Congress of Parkinson's Disease and Movement Disorders, held in Barcelona, Spain.

Recessive parkin genes have now been implicated in early-onset Parkinson's disease (PD), and mutations in genes coding for alpha synuclein and ubiquitin carboxy terminal hydrolase in families with the autosomal dominant type of PD, according to speaker Mihael Polymeropoulos of Novartis Pharmaceuticals Corp., Gaithersburg, Md. Thomas Gasser, of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies